drugset / Trial / NCT02405156

Letrozole Pretreatment With Misoprostol for Second-Trimester Medical Abortion

NCT02405156

Phase 2/3 Completed 400 enrolled Ain Shams University
RandomizedParallel-groupTriple-blindTreatment

Summary

To compare the success rate of letrozole and misoprostol versus misoprostol alone for medical termination of pregnancy in second trimester abortion.

Timeline

Start
2015-03
Primary completion
2016-12
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Letrozole Other / unclassified 7.5 mg Intravenous
Background Misoprostol Other / unclassified 100 ug Other
Background Misoprostol Other / unclassified 200 ug Other
Background Misoprostol Other / unclassified 400 ug Other